Table 3 Logistic regression for associated with poor neurologic outcome in 3 months (GOS 1–3)
Univariable analysis OR (CI 95 %) | p-value | Multivariable analysis OR (CI 95 %) | p-value | |
|---|---|---|---|---|
Age | 1.02 (1.01–1.04) | 0.013 | 1.04 (1.01–1.06) | 0.005 |
WFNS 5 | 4.32(2.62–7.13) | 0.001 | 3.23 (1.67–6.25) | 0.001 |
Intracranial hypertension | 10.14(5.87–17.51) | 0.001 | 10.15 (5.24–19.66) | 0.001 |
Rebleeding | 10.22(1.37–76.43) | 0.024 | 3.77 (0.46–30.56) | 0.215 |
Hydrocephalus | 0.64(0.40–1.03) | 0.068 | 0.66 (0.32–1.33) | 0.243 |
Intraparenchymal hematoma | 1.02 (0.63–1.64) | 0.940 | 0.90 (0.49–1.67) | 0.747 |
Endovascular treatment | 0.31(0.19–0.51) | 0.001 | 0.56 (0.29–1.09) | 0.087 |
Prophylactic nimodipine | 9.27(2.20-39.04) | 0.001 | 0.29 (0.11–0.77) | 0.013 |
2008–2011 | 0.84 (0.40–1.76) | 0.645 | 1.12 (0.44–2.85) | 0.809 |
2012–2015 | 0.97 (0.49–1.90) | 0.924 | 0.71 (0.28–1.85) | 0.487 |
2016–2018 | 1.14 (0.56–2.32) | 0.727 | 1.26 (0.48–3.27) | 0.638 |